Population Pharmacokinetics Analysis of Nivolumab in Asian and Non-Asian Patients With Gastric and Gastro-Esophageal Junction Cancers

Cancer Chemotherapy and Pharmacology - Germany
doi 10.1007/s00280-019-03771-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Asian and Non-Asian Morbidity in Hospitals.

BMJ
1983English

Asian and Non-Asian Morbidity in Hospitals

BMJ
1983English

Anti-Vegf Therapy in mRCC: Differences Between Asian and Non-Asian Patients

British Journal of Cancer
Cancer ResearchOncology
2014English

Nivolumab in Advanced Hepatocellular Carcinoma: Sorafenib-Experienced Asian Cohort Analysis

Journal of Hepatology
Hepatology
2019English

Comparison of Efficacy and Safety of Two Starting Insulin Regimens in Non-Asian, Asian Indian, and East Asian Patients With Type 2 Diabetes: A Post Hoc Analysis of the PARADIGM Study

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal MedicinePharmacology
2016English

Survival Trends of Cancer Amongst the South Asian and Non-South Asian Population Under 30 Years of Age in Yorkshire, UK

Cancer Epidemiology
Cancer ResearchEpidemiologyOncology
2012English

A Phase I Dose-Escalation Study of IMAB362 (Zolbetuximab) in Patients With Advanced Gastric and Gastro-Oesophageal Junction Cancer

European Journal of Cancer
Cancer ResearchOncology
2018English

Nickel Sensitization in Patients With Gastro-Esophageal Reflux Disease

United European Gastroenterology Journal
OncologyGastroenterology
2015English

Multidisciplinary Management of Stage II-III Gastric and Gastro-Oesophageal Junction Cancer

European Journal of Cancer
Cancer ResearchOncology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy